Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4
作者： Daniel S. Streetman , Stephen M. Stout
DOI: 10.1503/CMAJ.150030
关键词:
摘要: See also research article on page [174][1] and at [www.cmaj.ca/lookup/doi/10.1503/cmaj.140950][2] Considerable data support the use of statins for prevention atherosclerotic cardiovascular diseases.[1][3] An estimated 25 million patients worldwide are taking a statin,[1][3],[2][4]
sci-hub.se 参考文章(10)
A Kalliokoski, M Niemi, Impact of OATP transporters on pharmacokinetics British Journal of Pharmacology. ,vol. 158, pp. 693- 705 ,(2009) , 10.1111/J.1476-5381.2009.00430.X
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden, Q Feng, R M Cooper-DeHoff, L Gong, T E Klein, M Wadelius, M Niemi, The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update Clinical Pharmacology & Therapeutics. ,vol. 96, pp. 423- 428 ,(2014) , 10.1038/CLPT.2014.125
Rhianna M. Tuchscherer, Kavita Nair, Vahram Ghushchyan, Joseph J. Saseen, Simvastatin Prescribing Patterns Before and After FDA Dosing Restrictions: A Retrospective Analysis of a Large Healthcare Claims Database American Journal of Cardiovascular Drugs. ,vol. 15, pp. 27- 34 ,(2015) , 10.1007/S40256-014-0096-X
David A. Morrow, Potassium Levels After Acute Myocardial Infarction—Reply JAMA. ,vol. 307, pp. 1578- 1580 ,(2012) , 10.1001/JAMA.2012.488
Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones, Patrick McBride, J Sanford Schwartz, Susan T Shero, Sidney C Smith Jr, Karol Watson, Peter WF Wilson, None, 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation. ,vol. 129, pp. 2889- 2934 ,(2014) , 10.1161/01.CIR.0000437738.63853.7A
A Alfirevic, D Neely, J Armitage, H Chinoy, R G Cooper, R Laaksonen, D F Carr, K M Bloch, J Fahy, A Hanson, Q-Y Yue, M Wadelius, A H Maitland-van Der Zee, D Voora, B M Psaty, C N A Palmer, M Pirmohamed, Phenotype Standardization for Statin‐Induced Myotoxicity Clinical Pharmacology & Therapeutics. ,vol. 96, pp. 470- 476 ,(2014) , 10.1038/CLPT.2014.121
Jamie L Fleet, Salimah Z Shariff, David G Bailey, Sonja Gandhi, David N Juurlink, Danielle M Nash, Muhammad Mamdani, Tara Gomes, Amit M Patel, Amit X Garg, Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions BMJ Open. ,vol. 3, ,(2013) , 10.1136/BMJOPEN-2013-002857
Daniel Q. Li, Richard Kim, Eric McArthur, Jamie L. Fleet, David G. Bailey, David Juurlink, Salimah Z. Shariff, Tara Gomes, Muhammad Mamdani, Sonja Gandhi, Stephanie Dixon, Amit X. Garg, Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4 Canadian Medical Association Journal. ,vol. 187, pp. 174- 180 ,(2015) , 10.1503/CMAJ.140950
Susan R. Heckbert, Use of Administrative Data to Estimate the Incidence of Statin-Related Rhabdomyolysis JAMA. ,vol. 307, pp. 1580- 1582 ,(2012) , 10.1001/JAMA.2012.489
Michael J. Pencina, Ann Marie Navar-Boggan, Ralph B. D'Agostino, Ken Williams, Benjamin Neely, Allan D. Sniderman, Eric D. Peterson, Application of New Cholesterol Guidelines to a Population-Based Sample The New England Journal of Medicine. ,vol. 60, pp. 1422- 1431 ,(2014) , 10.1056/NEJMOA1315665